Clal Biotechnology (Israel) Price Prediction and Hype Density Breakdown

CBI -- Israel Stock  

ILS 310.10  3.30  1.05%

We analyze noise-free headlines and recent hype associated with Clal Biotechnology Industries Ltd which may create opportunities for some arbitrage if properly timed. With Clal Biotechnology hype-based prediction module you can estimate the value of Clal Biotechnology Industries Ltd from the prospective of Clal Biotechnology response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on Clal Biotechnology over a specific investment horizon. Check also Clal Biotechnology Basic Forecasting Models to cross-verify your projections.
Horizon     30 Days    Login   to change

Clal Biotechnology After-Hype Price Density Analysis

 Next price density 
      Expected price to next headline 

Clal Biotechnology Estimiated After-Hype Price Volatility

December 13, 2018
Current Value
After-hype Price
Target Odds
Clal Biotechnology is not too risky asset. Analysis and calculation of next after-hype price of Clal Biotechnology is based on 2 months time horizon.

Clal Biotechnology Next Price Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.37% 1.73% 0.70%  0.23% 3 Events / Month6 Events / MonthIn about 3 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Clal Biotechnology Hype Timeline

Clal Biotechnology Industries Ltd is currently traded for 310.10on Tel Aviv Stock Exchange of Israel. This company has historical hype elasticity of -0.7 and average elasticity to hype of competition of -0.23. Clal Biotechnology Industries Ltd is anticipated to decline in value after the next headline with price expected to drop to 309.4. The average volatility of media hype impact on the company stock price is about 91.05%. The price drop on the next news is expected to be -0.23% where as daily expected return is currently at -0.37%. The volatility of related hype on Clal Biotechnology is about 283.61% with expected price after next announcement by competition of 309.87. The company recorded loss per share of 0.39. Clal Biotechnology Industries Ltd had not issued any dividends in recent years. Assuming 30 trading days horizon, the next anticipated press release will be in about 3 days.
Check also Clal Biotechnology Basic Forecasting Models to cross-verify your projections.

Clal Biotechnology Related Hype Analysis

At Risk
Kamada Ltd(11.00) 4 per month 0.00 (0.16)  2.32 (2.64)  6.96 
RedHill Biopharma Ltd 7.70 5 per month 4.02  0.0201  6.86 (6.55)  22.64 
BioTime 8.00 1 per month 0.00 (0.29)  5.65 (9.78)  16.21 
Compugen Ltd(2.00) 7 per month 0.00 (0.08)  3.52 (4.38)  15.94 
Clal Biotechnology Industries Ltd(1.90) 3 per month 0.00 (0.08)  2.92 (3.33)  9.16 
Pluristem Therapeutics 4.00 6 per month 0.00 (0.25)  2.93 (4.02)  14.07 
Evogene Ltd(7.90) 5 per month 0.00 (0.19)  3.24 (3.32)  10.17 
Protalix BioTherapeutics 0.70 1 per month 0.00  0.0052  14.13 (10.35)  29.36 
Can Fite BioPharma Ltd(3.70) 4 per month 2.07  0.05  4.04 (3.69)  14.85 
Solegreen Ltd 0.00 1 per month 1.33  0.0396  3.32 (2.34)  7.75 

Latest Stories

Recently Published Macroaxis Stories

Investors are also interested in

Purchased over 50 shares
Active 2 days ago
Purchased over 20 shares
Active 2 days ago
Purchased over 50 shares
Active 2 days ago
Check also Clal Biotechnology Basic Forecasting Models to cross-verify your projections. Please also try Instant Ratings module to determine any equity ratings based on digital recommendations. macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.